Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 5 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 17 |
NetGPI | no | yes: 0, no: 17 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005930 | axoneme | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AJY1
Term | Name | Level | Count |
---|---|---|---|
GO:0006810 | transport | 3 | 1 |
GO:0006897 | endocytosis | 5 | 1 |
GO:0016192 | vesicle-mediated transport | 4 | 1 |
GO:0051179 | localization | 1 | 1 |
GO:0051234 | establishment of localization | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 144 | 148 | PF00656 | 0.339 |
CLV_C14_Caspase3-7 | 15 | 19 | PF00656 | 0.373 |
CLV_PCSK_FUR_1 | 184 | 188 | PF00082 | 0.275 |
CLV_PCSK_KEX2_1 | 186 | 188 | PF00082 | 0.275 |
CLV_PCSK_KEX2_1 | 209 | 211 | PF00082 | 0.256 |
CLV_PCSK_KEX2_1 | 300 | 302 | PF00082 | 0.415 |
CLV_PCSK_PC1ET2_1 | 186 | 188 | PF00082 | 0.275 |
CLV_PCSK_PC1ET2_1 | 209 | 211 | PF00082 | 0.256 |
CLV_PCSK_PC1ET2_1 | 300 | 302 | PF00082 | 0.390 |
CLV_PCSK_SKI1_1 | 146 | 150 | PF00082 | 0.503 |
DOC_MAPK_gen_1 | 24 | 30 | PF00069 | 0.431 |
DOC_MAPK_MEF2A_6 | 158 | 165 | PF00069 | 0.240 |
DOC_MAPK_NFAT4_5 | 158 | 166 | PF00069 | 0.235 |
DOC_USP7_MATH_1 | 242 | 246 | PF00917 | 0.308 |
DOC_USP7_UBL2_3 | 142 | 146 | PF12436 | 0.413 |
DOC_USP7_UBL2_3 | 229 | 233 | PF12436 | 0.296 |
LIG_deltaCOP1_diTrp_1 | 250 | 256 | PF00928 | 0.402 |
LIG_deltaCOP1_diTrp_1 | 50 | 56 | PF00928 | 0.357 |
LIG_EH1_1 | 163 | 171 | PF00400 | 0.446 |
LIG_FHA_1 | 305 | 311 | PF00498 | 0.469 |
LIG_FHA_1 | 75 | 81 | PF00498 | 0.380 |
LIG_FHA_2 | 45 | 51 | PF00498 | 0.470 |
LIG_GBD_Chelix_1 | 155 | 163 | PF00786 | 0.239 |
LIG_LIR_Gen_1 | 270 | 280 | PF02991 | 0.262 |
LIG_LIR_Nem_3 | 234 | 239 | PF02991 | 0.338 |
LIG_LIR_Nem_3 | 285 | 291 | PF02991 | 0.411 |
LIG_LYPXL_yS_3 | 288 | 291 | PF13949 | 0.431 |
LIG_Pex14_1 | 52 | 56 | PF04695 | 0.380 |
LIG_Pex14_2 | 67 | 71 | PF04695 | 0.462 |
LIG_REV1ctd_RIR_1 | 107 | 118 | PF16727 | 0.273 |
LIG_SH2_CRK | 81 | 85 | PF00017 | 0.351 |
LIG_SH2_GRB2like | 218 | 221 | PF00017 | 0.268 |
LIG_SH2_NCK_1 | 34 | 38 | PF00017 | 0.461 |
LIG_SH2_SRC | 218 | 221 | PF00017 | 0.256 |
LIG_SH2_STAP1 | 34 | 38 | PF00017 | 0.403 |
LIG_SH2_STAT5 | 120 | 123 | PF00017 | 0.268 |
LIG_SH2_STAT5 | 182 | 185 | PF00017 | 0.284 |
LIG_SH2_STAT5 | 218 | 221 | PF00017 | 0.270 |
LIG_SH2_STAT5 | 29 | 32 | PF00017 | 0.387 |
LIG_SH3_3 | 300 | 306 | PF00018 | 0.390 |
LIG_TYR_ITIM | 286 | 291 | PF00017 | 0.319 |
MOD_CK1_1 | 101 | 107 | PF00069 | 0.421 |
MOD_CK1_1 | 60 | 66 | PF00069 | 0.504 |
MOD_CK1_1 | 74 | 80 | PF00069 | 0.320 |
MOD_CK2_1 | 264 | 270 | PF00069 | 0.366 |
MOD_CK2_1 | 44 | 50 | PF00069 | 0.563 |
MOD_Cter_Amidation | 111 | 114 | PF01082 | 0.268 |
MOD_Cter_Amidation | 184 | 187 | PF01082 | 0.275 |
MOD_GlcNHglycan | 100 | 103 | PF01048 | 0.248 |
MOD_GlcNHglycan | 224 | 227 | PF01048 | 0.298 |
MOD_GlcNHglycan | 307 | 310 | PF01048 | 0.383 |
MOD_GlcNHglycan | 61 | 65 | PF01048 | 0.488 |
MOD_GlcNHglycan | 91 | 94 | PF01048 | 0.254 |
MOD_GSK3_1 | 121 | 128 | PF00069 | 0.253 |
MOD_GSK3_1 | 44 | 51 | PF00069 | 0.547 |
MOD_NEK2_1 | 293 | 298 | PF00069 | 0.392 |
MOD_NEK2_1 | 71 | 76 | PF00069 | 0.282 |
MOD_Plk_2-3 | 44 | 50 | PF00069 | 0.496 |
MOD_Plk_4 | 196 | 202 | PF00069 | 0.266 |
MOD_Plk_4 | 264 | 270 | PF00069 | 0.391 |
MOD_Plk_4 | 48 | 54 | PF00069 | 0.388 |
MOD_SUMO_for_1 | 141 | 144 | PF00179 | 0.283 |
MOD_SUMO_rev_2 | 139 | 148 | PF00179 | 0.426 |
MOD_SUMO_rev_2 | 267 | 273 | PF00179 | 0.387 |
MOD_SUMO_rev_2 | 3 | 9 | PF00179 | 0.616 |
TRG_ENDOCYTIC_2 | 216 | 219 | PF00928 | 0.233 |
TRG_ENDOCYTIC_2 | 288 | 291 | PF00928 | 0.431 |
TRG_NES_CRM1_1 | 154 | 167 | PF08389 | 0.237 |
TRG_Pf-PMV_PEXEL_1 | 278 | 282 | PF00026 | 0.501 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HVW7 | Leptomonas seymouri | 80% | 100% |
A0A0S4IT41 | Bodo saltans | 54% | 100% |
A0A0S4KIY0 | Bodo saltans | 33% | 91% |
A0A1X0P8X9 | Trypanosomatidae | 58% | 100% |
A0A3S7XBA2 | Leishmania donovani | 24% | 100% |
A0A451EJU5 | Leishmania donovani | 94% | 100% |
A4H3Q9 | Leishmania braziliensis | 84% | 100% |
A4HPP6 | Leishmania braziliensis | 22% | 100% |
A4HRY3 | Leishmania infantum | 94% | 100% |
A4ID18 | Leishmania infantum | 24% | 100% |
C9ZKJ2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 60% | 100% |
C9ZRE1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 31% | 91% |
E9ACP2 | Leishmania major | 94% | 100% |
E9ATG0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 24% | 100% |
Q4Q6V8 | Leishmania major | 30% | 91% |
V5DTY1 | Trypanosoma cruzi | 61% | 100% |